Home / Business and Economy / Anupam Rasayan Buys Into Bliss GVS Pharma
Anupam Rasayan Buys Into Bliss GVS Pharma
24 May
Summary
- Anupam Rasayan plans to acquire a significant stake in Bliss GVS Pharma.
- The deal involves an open offer to acquire additional shares.
- Bliss GVS Pharma has manufacturing facilities and global exports.
Specialty chemicals maker Anupam Rasayan India Ltd. has entered into a definitive agreement to acquire a 43.3% stake in pharmaceutical company Bliss GVS Pharma Ltd. for approximately Rs 1,369.51 crore. The company will also make an open offer to acquire an additional 26% stake from public shareholders at Rs 299 per share. This acquisition aims to strengthen Anupam Rasayan's presence across the pharmaceutical value chain, from key starting materials to finished dosage formulations.
Bliss GVS Pharma, a company established in 1984, develops and exports various formulations including suppositories, tablets, capsules, and injectables. It holds EU-GMP certification and operates manufacturing facilities in Maharashtra and Daman, with approvals from the USFDA and WHO. The company boasts a portfolio of over 150 branded formulations and is a leading manufacturer of suppositories and pessaries, with a significant presence in Africa, Asia, and Latin America.
The combined entity is expected to create an integrated pharmaceutical manufacturing platform with enhanced backward integration and expanded reach into regulated markets like Europe and the United States. Anupam Rasayan reported a 40% increase in its consolidated net profit to Rs 222.19 crore for the fiscal year 2025-26, up from Rs 159.9 crore in the previous year.
